Alerts will be sent to your verified email
Verify Email
VAISHALI
|
Vaishali Pharma
|
Coral Laboratories
|
Quest Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.61 % | 6.99 % | 30.21 % |
|
5yr Avg Net Profit Margin
|
3.52 % | 12.64 % | 7.37 % |
|
Price to Book
|
2.45 | 0.83 | 0.0 |
|
P/E
|
399.25 | 9.4 | 12.02 |
|
5yr Avg Cash Conversion Cycle
|
133.52 Days | 26.14 Days | 1.67 Days |
|
5yr Average Interest Coverage Ratio
|
2.44 | 114.88 | 14.47 |
|
5yr Avg ROCE
|
16.76 % | 8.79 % | 39.56 % |
|
5yr Avg Operating Profit Margin
|
6.18 % | 11.85 % | 11.77 % |
|
5 yr average Debt to Equity
|
0.6 | 0.03 | 0.32 |
|
5yr CAGR Net Profit
|
88.82 % | 17.24 % | 72.53 % |
|
5yr Average Return on Assets
|
3.1 % | 5.83 % | 10.78 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
26.32 % | 71.51 % | 66.21 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.42 % | 0.0 | 0.38 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vaishali Pharma
|
Coral Laboratories
|
Quest Laboratories
|
|---|